The Comparision of Minimally-invasive and Open Pancreaticoduodenectomy for Pancreatic Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorPeking Union Medical College Hospital
About this trial
Minimally invasive pancreaticoduodenectomy remains one of the most challenging abdominal procedures. Safety and feasibility remain controversial when comparing minimally-invasive with open pancreaticoduodenectomy, especially for malignant tumors.The aim of this study was to compare minimally invasive and open pancreatoduodenectomy for short-term outcomes and long-term follow-up in a randomized trial.
Eligibility criteria
Qualifiers
Age: >18yr, <75yr
Patients with pancreatic cancer or non-pancreatic cancers (biliary duct cancer or ampullary cancer) who underwent pancreatoduodenectomy
Preoperative imaging assessment is resectable or borderline resectable
Disqualifiers
Benign tumors of the head of pancreas
Enhanced CT diagnosis revealed that the excess of SMV was more than 180 degrees, or distant metastasis.
conversion to laparotomy because of intraoperative difficulty
Trial design
Treatments tested in this trial
- Minimally-invasive pancreaticoduodenectomy
- Open pancreaticoduodenectomy
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov